← Open Payments lookup

SHEILA SETTLEMIRES: Open Payments

NPI 1033531942 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$405 in 22 payments from 9 companies in 2025. Trend: 2023 $148 · 2024 $95 · 2025 $405

Food & beverage: $405
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$100
ABBVIE INC.3$52
Novo Nordisk Inc3$46
Bayer Healthcare Pharmaceuticals Inc.2$39
Esperion Therapeutics, Inc.2$37
Lilly USA, LLC2$35
GlaxoSmithKline, LLC.2$33
Amgen Inc.2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$30

Products named: AIRSUPRA, Kerendia, FARXIGA, VRAYLAR, NEXLETOL, TRELEGY ELLIPTA, CAPLYTA, Rybelsus.

Industry payments across MS — which companies pay providers there.